Please login to the form below

Not currently logged in
Email:
Password:

UK NHS must change says health chief

The PM Society's annual lecture hears that the UK's National Health Service is not sustainable in its current state

Pharmaceutical companies, the government, primary care trusts (PCTs) and GP consortia need to pull together to tackle the "tsunami" of long-term conditions that the UK health service is facing, the PM Society annual lecture heard.

Sir John Oldham, the Department of Health's national clinical lead for quality and productivity, told guests: "If we continue to manage people with long-term conditions as we do now the NHS is not sustainable. It's not about politics, it's about mathematics.

"We have to make a change. There are ways to treat people with multiple conditions to reduce hospital stays. The pharma industry can help by transferring knowledge to patients so they can co-manage their conditions. We need to shift from a bio-medical model to a social model," he added.

Meanwhile Leslie Galloway, chairman of the Ethical Medicines Industry Group, discussed value based pricing. "Many see it as a threat, but it is not designed to increase prices. We need constant pricing across the UK," he told the guests.

19th May 2011

From: Healthcare

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics